Senior Director, Late-Stage Program Management

The Role:

Reporting to the Head of Program Management, Generate:Biomedicines is seeking a motivated, proactive and action oriented Sr. Director to act as a “COO” for our most advanced program GB-0895 that recently commenced multiple Phase 3 trials across multiple indications. This is a critical role interfacing across multiple cross functional leaders to enable efficient and comprehensive execution of the goals, objectives and strategy of this program. The successful candidate will work in partnership with the Chief Medical Officer of I&I and the cross-functional Program Team to enable translation of the program strategy to a tactical plan for execution. The successful candidate will have strong program management, leadership and drug development experience in late stage clinical development and BLA submissions. Experience across other stages of discovery and development would also be valued. The Sr. Director must thrive in a fast-paced, ambiguous, highly interdisciplinary entrepreneurial environment, and have the desire to tackle large challenges.

Here's how you will contribute:

• This role partners with the Chief Medical Officer I&I in their role as the strategic partner and operational lead for Generate’s Immunology Phase 3 program GB-0895 
• The Sr. Director will develop, maintain and control the integrated program timelines at the program team level.  This includes the tracking of progress (baseline vs. latest estimate) made on key activities, tasks, deliverables, milestones and stage gate decisions; owning of scenario planning relative to scope, time, cost impact as part of effective decision making; identify activities on the critical path; and communicating the status of the program to key stakeholders.
• Individual will demonstrate creativity and resourcefulness in identifying, monitoring and mitigating risks and issues such that development programs execute according to plan.
• Building relationships with key stakeholders (program leader, functional team members and leadership) to ensure alignment of program, functional and company objectives to deliver the program strategy and promote program goals.
• Coordinating the program team’s day-to-day communications, including, facilitating cross-functional team meetings, leading discussions to drive decision-making, scenario planning, preparing agendas and meeting minutes, defining and resolving risks and issues.
• Partnering with Finance to develop and track program budgets and resource plans
• Providing oversight of third-party vendor activities and strategies which include status of vendor deliverables and third-party vendor metrics data.
• Supporting R&D processes as they relate to vendor operational qualification/documentation and vendor performance management 
• Investing time in coaching, mentoring and acting as a role model for other program managers to enhance their skills and performance at a higher level.

The Ideal Candidate will have:

• Bachelors degree in life sciences or business-related field; PhD and/or MBA preferred.
• 12+ years life biopharma industry experience, including minimum of 8 years with direct program management experience in biotechnology or pharma industries, is required. Flexibility to consider director or senior director level depending on ones relevant experience. 
• Experience with program management of late-stage (Phase 3) clinical programs and BLA submissions, is required
• Outstanding interpersonal skills with a demonstrated ability to build alignment and drive resolution of issues while maintaining positive working relationships across functions
• Ability to effectively apply program management principles including, but not limited to, identifying critical paths, building and communicating timelines, defining milestones and methods for setting expectations and accountability.

Preferred Qualifications:

• Project/program management certification
• Experience in Immunology indications
• Excellent written and verbal skills and strong interpersonal skills
• Demonstrated ability to provide effective program management excellence in terms of setting program plans for the lifecycle of a program from discovery through commercial launch

Location: This role will be located at our headquarters in Somerville, MA with an onsite presence expected with hybrid flexibility. 

About Generate:Biomedicines

We are a clinical-stage generative biology company pioneering the AI revolution in drug design and development. We are advancing a new approach to drug creation—one grounded in the ability to design proteins with defined biological intent. By integrating machine learning with large-scale experimentation, this approach aims to reduce the uncertainty, time, and cost associated with developing protein-based medicines.

Founded in 2018, we are advancing a growing pipeline of clinical and preclinical programs across multiple disease areas and protein modalities. By unifying computational design and clinical development within a single operating model, we translate this approach into clinical-stage programs and are leading a shift from traditional drug discovery toward systematic drug generation.

At Generate:Biomedicines, we collaborate across disciplines in new ways to invent and innovate. We bring diverse perspectives to a shared goal of delivering better medicines to patients in need, faster, guided by our values and leadership behaviors.

#LI-HM1

Generate:Biomedicines is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies: Generate:Biomedicines does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Generate:Biomedicines or its employees is strictly prohibited unless contacted directly by the Company’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Generate:Biomedicines and the Company will not owe any referral or other fees with respect thereto.